We are happy to announce we will be speaking at OBN's BioTrinity 2024 conference!
The Cell and Gene Therapy Catapult will be speaking on the Business Track at this two-day event.
Speaking from the Cell and Gene Therapy Catapult
Talk: 23rd April, 13:30 - 14:30: "Panel: A Discussion on the latest regulatory updates impacting biotech and medtech SMEs. How to ensure compliance and overcome challenges?"
Speaker: Chris Carr, Head of Regulatory Affairs